S
Surface Oncology Inc
F:QSOA
Surface Oncology Inc
F:QSOA
Price:
0.994
EUR
Market Cap:
€60.4m
Relative Value
There is not enough data to reliably calculate the relative value of QSOA.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
QSOA
Relative Value
Base Case
Not Available
Multiples Across Competitors
QSOA Competitors Multiples
Surface Oncology Inc Competitors
Surface Oncology Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
S
|
Surface Oncology Inc
F:QSOA
|
60.4m EUR | 0 | -0.8 | -0.2 | -0.2 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 643 258.8 | -159 901.4 | -194 171.3 | -191 955.6 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
396B USD | 6.6 | 168.9 | 16.4 | 23.2 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
202.6B USD | 5.4 | 25.8 | 14.8 | 14.8 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
188B USD | 6.4 | 23.1 | 15.7 | 15.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
119.6B USD | 10.2 | 32.5 | 23.9 | 25 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 094 | -534.3 | -581.8 | -566.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82B USD | 5.7 | 18 | 15.3 | 17.4 | |
| AU |
|
CSL Ltd
ASX:CSL
|
89B AUD | 4 | 20.6 | 13.8 | 17.2 | |
| NL |
|
argenx SE
XBRU:ARGX
|
42.7B EUR | 14.4 | 33.8 | 57.7 | 59.3 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.2 | -61.8 | -66.7 | -60.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
